UK Parliament / Open data

Genetic Technology (Precision Breeding) Bill

My Lords, I rise to speak from the Lib Dem Benches. Sadly, my noble friend Lady Bakewell of Hardington Mandeville is in hospital today, but she hopes to be back fighting the good fight in Committee.

These Benches are not anti-science. Although the noble Lord, Lord Lilley, is not in his place, I was surprised but delighted that he knows so much about Lib Dem policy to confirm that we are not against gene editing. We are not anti-science, and we see that there are benefits to gene editing. We accept that it is happening now and that there are clear benefits. However, the point of a regulatory process is to manage those benefits and risks in an appropriate way. That is the starting point of good regulation. While we can say that where we were 20 years ago is no longer appropriate, in this House we need to make sure that this new piece of legislation does the job of managing risks and benefits appropriately.

My starting point was to look at the Explanatory Notes to understand the Government’s thinking and why they are doing this. The overview of the Bill boldly and simply states:

“This Bill intends to reduce the regulatory burden and financial barriers in place for researchers and commercial breeders using precision breeding technologies.”

There is nothing about the best system to manage the risks and benefits. If one was to be unkind, one could say that it was driven by a deregulation agenda and nothing more. However, our concern on these Benches is that we have a process to manage those risks and benefits.

We have heard a lot about the benefits, which I accept. We have heard less about the risks, but they are out there. From the environmental side, the speed with which organisms can be bred means that they could be out of sync with other environmental factors, and indeed the landscape and the soils in which they live. However, it is particularly among animals where those off-target mutations—in the phrase the noble Lord, Lord Winston, used—are most common. Indeed, the Government’s own advisory committee, ACRE, says that the unintended DNA introductions are found predominantly among animals. That is the area of particular risk where I have concerns that this proposed regulation does not go far enough.

Let me start where the noble Lord, Lord Rooker, did: with the issue of consumer choice and ensuring that they are involved in this process. Whatever we think about gene editing, it will have profound societal and environmental system changes. As a liberal, I believe that the public should be consulted and should have their say on changes that concern the food that they eat and the environment in which they live and work and which they enjoy. I think it would be fair to argue that, so far, the Government have been sleeping on the job when it comes to involving the public and having the conversation about what gene editing will mean for their food and environment. The noble Earl, Lord Devon, referred to the SI that was introduced last year, and he rightly identified that the majority of people and businesses were overwhelmingly opposed: 88% were opposed to changing the regulation of gene

editing from what it is at the moment, which is analogous with GMOs. So, the public have not been persuaded, and the Government, to my mind, have not done a good enough job of making the case.

Equally, as others have said, the FSA did a piece of research which showed overwhelmingly that the public wanted this produce to be labelled, yet its response is that it will be on a register. I feel sorry for the noble Lord, Lord Krebs, who faced such opprobrium many years ago when he was in charge. If there is any opprobrium out there, it should be for coming up with the idea of a register when the debate about where we are with our food and society has moved on to such a degree that Defra itself is looking at introducing a labelling system next year that will look at a whole raft of issues of concern to the public. However, we are not accepting that, in this instance, labelling is absolutely fundamental to giving the products credibility and giving people the confidence in them that they need. As other Members around the House have said, if there are benefits—and there are benefits to gene editing—there should be no worry about putting labels on the products. The fact that the Government are removing that traceability and labelling from the current regulations is one of our fundamental concerns with what is being proposed.

Secondly, as a number of noble Lords around the House raised, we do not want to deregulate the system in such a way that allows the further suffering of our farm animals from further intensification. We need to make sure that that does not happen. The noble Baroness, Lady Jones of Whitchurch, referred to the Nuffield Council on Bioethics and its very clear position that we should not allow a regulatory process which bakes that in. As the noble Lord, Lord Cameron of Dillington, said, the way to overcome that is to have a really strong animal welfare advisory body, which is clear about who is on it and what its remit is. At the moment, we do not know who is going to be on it—that has been left to secondary regulation—and its remit is very narrow. All it can do is ensure that the developers have taken what they argue are the necessary steps to identify the welfare traits. That is absolutely not strong enough; we need much greater clarity on the face of the Bill around the animal welfare advisory body. That will give us some of the assurances we need that the Bill will not bake in further unnecessary suffering in terms of animal welfare.

Another really important point that the noble Lord, Lord Winston, raised was about reporting and monitoring. The analogous piece of legislation, the Human Fertilisation and Embryology Act, identifies the reporting mechanisms there are for people to say what the adverse traits of these activities might be, both for the individual animals and their future progeny—it is included in the Act. I think that is analogous and that we should be arguing for something similar in the Bill. Indeed, the British Veterinary Association—I am very grateful for its briefing on this—are particularly concerned about the need for clear reporting and monitoring and the fact that it is not in the Bill. That is certainly something that we will be seeking to amend in Committee.

I will make another point about animals. We may have views about how appropriate it is to use gene editing to fashion our animals and various other things.

I would prefer the Bill to be limited to farm animals because I am extremely worried about some of the impacts for wild animals, including highly mobile fish and insects. I feel that it would be far better for us to concentrate on farm animals, as the Minister knows. He very kindly gave a briefing to a number of groups, during which I asked him who had actually asked for any extension beyond farm animals in the scope of the Bill. He confirmed that nobody had asked for it, but that—as the noble Lord, Lord Krebs, said—this is about future-proofing. That is not good enough; you cannot just future-proof when there is such uncertainty around this use of animals. So, at the very least, we should be constraining this back to agricultural animals.

The third issue—which I will discuss briefly to limit my speech to 10 minutes—is on trade. A number of other noble Lords have mentioned this: our biggest number of exports are to Europe. While the Europeans are of course looking at this issue, my fairly sure understanding is that the French and the Germans are still opposed at the moment, so we are not there yet with them. But, even if they were to move forward, there will be two issues. First, as the noble Lord, Lord Curry, said, they may not have exactly the same situation or one that is analogous, so how can we ensure that we do not put barriers for our trade in advance by having a system which is out of step with what Europe is doing? We might come to an agreement within the next year; it is possible. The second point, which nobody has raised, is that the Europeans are not looking at animals at all; it is off the table. Therefore, all the people producing British meat, dairy, yoghurt and eggs will face friction in their trade, delivered to them by this Government, because Europe is not going to allow it. So a Government who have prided themselves on cutting red tape—I applaud them for the sentiment—if they go ahead with allowing gene editing for farm animals, are not going to be able to sell into Europe in a frictionless way. This is because the Europeans are not looking to change their proposals around gene-edited animals.

Equally, on the point made by the noble Earl, Lord Stair, the devolved Administrations are really uncomfortable with this proposal, to put it mildly. Therefore, labelling, in addition to being an answer for consumers, is an answer for trade, because that gives traceability and certainty for producers, both to our major export markets and across the devolved nations.

I said that I would stick to 10 minutes, so I will conclude by saying that we are not against gene editing, but we need a system which balances the benefits and the risks. This is going too far: it is too light-touch, it does not have the reassurances for consumers, animal welfare or trade, and it needs to be amended by this House or it will be repented at leisure.

8.04 pm

Type
Proceeding contribution
Reference
825 cc1240-2 
Session
2022-23
Chamber / Committee
House of Lords chamber
Back to top